Stanley Laman Group Ltd. Has $6.02 Million Stock Position in Intuitive Surgical, Inc. $ISRG

Stanley Laman Group Ltd. increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2,091.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,456 shares of the medical equipment provider’s stock after acquiring an additional 12,842 shares during the period. Intuitive Surgical comprises about 0.9% of Stanley Laman Group Ltd.’s holdings, making the stock its 26th largest holding. Stanley Laman Group Ltd.’s holdings in Intuitive Surgical were worth $6,018,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Tobam lifted its position in shares of Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares in the last quarter. Kilter Group LLC purchased a new position in Intuitive Surgical during the second quarter valued at approximately $27,000. Princeton Global Asset Management LLC acquired a new position in Intuitive Surgical in the 2nd quarter valued at approximately $30,000. Riggs Asset Managment Co. Inc. increased its stake in Intuitive Surgical by 84.2% in the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock valued at $38,000 after buying an additional 32 shares during the period. Finally, CBIZ Investment Advisory Services LLC lifted its position in Intuitive Surgical by 49.1% in the 1st quarter. CBIZ Investment Advisory Services LLC now owns 82 shares of the medical equipment provider’s stock worth $41,000 after buying an additional 27 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other news, EVP Myriam Curet sold 104 shares of the company’s stock in a transaction that occurred on Wednesday, December 10th. The stock was sold at an average price of $559.90, for a total value of $58,229.60. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Gary S. Guthart sold 22,806 shares of the company’s stock in a transaction on Monday, December 1st. The shares were sold at an average price of $570.89, for a total value of $13,019,717.34. Following the completion of the sale, the insider owned 2,694 shares in the company, valued at $1,537,977.66. This trade represents a 89.44% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 114,007 shares of company stock valued at $63,533,844. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on ISRG. HSBC boosted their price target on shares of Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Evercore ISI lifted their price objective on Intuitive Surgical from $450.00 to $540.00 in a research report on Wednesday, October 22nd. Daiwa Capital Markets boosted their target price on Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research note on Friday, October 24th. Raymond James Financial set a $603.00 price target on Intuitive Surgical and gave the stock an “outperform” rating in a research note on Wednesday, October 22nd. Finally, The Goldman Sachs Group boosted their price target on Intuitive Surgical from $567.00 to $621.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Two research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $611.08.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $561.98 on Monday. The firm has a market capitalization of $201.46 billion, a price-to-earnings ratio of 74.34, a P/E/G ratio of 4.57 and a beta of 1.67. The company’s fifty day moving average is $561.47 and its two-hundred day moving average is $508.95. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical’s quarterly revenue was up 22.9% compared to the same quarter last year. During the same period last year, the business earned $1.84 earnings per share. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.